The effect of initial conservative hypotensive therapy on the outcomes of selective laser trabeculoplasty in primary open-angle glaucoma
- 29 October 2025
- journal article
- abstracts
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 141 (5) , 16-22
Abstract
Objective. The effect of the type of topical hypotensive therapy on the hypotensive effect of selective laser trabeculoplasty (SLT) in primary open-angle glaucoma (POAG). Material and methods. A retrospective analysis was performed on medical records of patients who received SLT for the first time and had no prior laser or surgical glaucoma treatment. SLT was performed according to the standard protocol, with 360° trabecula treatment. Patients were divided into five subgroups based on the number of hypotensive medications used (0 to 4) and into 15 subgroups according to the combinations of medications used before SLT. Intraocular pressure (IOP) levels before and after treatment were compared, and the IOP-lowering effect of SLT was evaluated at 1 day and 1 month postoperatively. Results. The study included 808 patients (808 eyes) with POAG stages I—III, who either received no hypotensive therapy (n=54) or were on one (n=169), two (n=233), three (n=307), or four (n=45) topical hypotensive medications. The hypotensive effect differed significantly among subgroups with different numbers of medications at 1 day after SLT (F=3.18; p=0.01). The greatest effect was observed in the subgroup receiving maximum therapy (5.0±3.3 (95% confidence interval (CI) 3.9—6.1) mm Hg), which decreased by 1 month and became the lowest among all subgroups (2.6±3.0 (95% CI 1.6—3.7) mm Hg). At 1 month, differences among subgroups were not statistically significant (F=2.21; p=0.07), although the greatest effect was seen in the subgroup without therapy (4.0±2.8 (95% CI 3.2—4.8) mm Hg). The effect of SLT did not significantly differ among the 15 subgroups with different types of pre-surgical therapy at either 1 day (F=1.65; p=0.28) or 1 month (F=1.19; p=0.06) after laser treatment. Conclusion. Selective laser trabeculoplasty is an effective method for additional IOP reduction in POAG, and its hypotensive effect does not depend on the number, type, or combination of hypotensive eye drops used before laser treatment.Keywords
This publication has 15 references indexed in Scilit:
- European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th EditionBritish Journal of Ophthalmology, 2021
- Is laser trabeculoplasty the new star in glaucoma treatment?Current Opinion in Ophthalmology, 2021
- Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trialThe Lancet, 2019
- Selective laser trabeculoplasty: past, present, and futureEye, 2018
- Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplastyCochrane Database of Systematic Reviews, 2017
- Intraocular pressure‐lowering medications and long‐term outcomes of selective laser trabeculoplastyClinical & Experimental Ophthalmology, 2014
- SLT and Adjunctive Medical TherapyJournal of Glaucoma, 2011
- Topical prostaglandin analogues do not affect selective laser trabeculoplasty outcomesEye, 2009
- Effect of Topical Prostaglandin Analog Use on Outcome Following Selective Laser TrabeculoplastyJournal of Ocular Pharmacology and Therapeutics, 2007
- Reduction of Intraocular Pressure and Glaucoma ProgressionArchives of Ophthalmology (1950), 2002